{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:37:48Z","timestamp":1791423468591,"version":"4.3.3"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"7950","license":[{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2023,3,2]]},"DOI":"10.1038\/s41586-023-05697-2","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T17:02:56Z","timestamp":1673456576000},"page":"143-150","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":129,"title":["Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation"],"prefix":"10.1038","volume":"615","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1957-3330","authenticated-orcid":false,"given":"Da-Yuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chue Vin","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin","family":"Kenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander H.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazimuddin","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7328-3521","authenticated-orcid":false,"given":"Hasahn L.","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2520-7625","authenticated-orcid":false,"given":"GuanQun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish C.","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans P.","family":"Gertje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7027-4267","authenticated-orcid":false,"given":"Aoife K.","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1472-0223","authenticated-orcid":false,"given":"Scott","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9604-8476","authenticated-orcid":false,"given":"Darrell N.","family":"Kotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Ensser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8867-7256","authenticated-orcid":false,"given":"John H.","family":"Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2773-1033","authenticated-orcid":false,"given":"Markus","family":"Bosmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9914-9662","authenticated-orcid":false,"given":"Jonathan Z.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2163-2598","authenticated-orcid":false,"given":"Michaela U.","family":"Gack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6485-8143","authenticated-orcid":false,"given":"Susan C.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5974-2709","authenticated-orcid":false,"given":"Robert N.","family":"Kirchdoerfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yachana","family":"Kataria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3873-9188","authenticated-orcid":false,"given":"Nicholas A.","family":"Crossland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Douam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8505-7054","authenticated-orcid":false,"given":"Mohsan","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,11]]},"reference":[{"key":"5697_CR1","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41586-021-04388-0","volume":"602","author":"L Liu","year":"2022","unstructured":"Liu, L. et al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2. Nature 602, 676\u2013681 (2022).","journal-title":"Nature"},{"key":"5697_CR2","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","volume":"602","author":"D Planas","year":"2022","unstructured":"Planas, D. et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature 602, 671\u2013675 (2022).","journal-title":"Nature"},{"key":"5697_CR3","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMc2119641","volume":"386","author":"F Schmidt","year":"2022","unstructured":"Schmidt, F. et al. Plasma neutralization of the SARS-CoV-2 Omicron variant. N. Engl. J. Med. 386, 599\u2013601 (2022).","journal-title":"N. Engl. J. Med."},{"key":"5697_CR4","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-022-04442-5","volume":"603","author":"H Shuai","year":"2022","unstructured":"Shuai, H. et al. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron. Nature 603, 693\u2013699 (2022).","journal-title":"Nature"},{"key":"5697_CR5","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41586-022-04441-6","volume":"603","author":"PJ Halfmann","year":"2022","unstructured":"Halfmann, P. J. et al. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters. Nature 603, 687\u2013692 (2022).","journal-title":"Nature"},{"key":"5697_CR6","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1038\/s41591-022-01887-z","volume":"28","author":"JA Lewnard","year":"2022","unstructured":"Lewnard, J. A. et al. Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1\/BA.1.1 or BA.2 subvariant infection in Southern California. Nat. Med. 28, 1933\u20131943 (2022).","journal-title":"Nat. Med."},{"key":"5697_CR7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0140-6736(22)00017-4","volume":"399","author":"N Wolter","year":"2022","unstructured":"Wolter, N. et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet 399, 437\u2013446 (2022).","journal-title":"Lancet"},{"key":"5697_CR8","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1001\/jama.2022.2274","volume":"327","author":"AC Ulloa","year":"2022","unstructured":"Ulloa, A. C., Buchan, S. A., Daneman, N. & Brown, K. A. Estimates of SARS-CoV-2 Omicron variant severity in Ontario, Canada. J. Am. Med. Assoc. 327, 1286\u20131288 (2022).","journal-title":"J. Am. Med. Assoc."},{"key":"5697_CR9","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41586-022-05482-7","volume":"612","author":"R Uraki","year":"2022","unstructured":"Uraki, R. et al. Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents. Nature 612, 540\u2013545 (2022).","journal-title":"Nature"},{"key":"5697_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41586-022-04856-1","volume":"607","author":"R Uraki","year":"2022","unstructured":"Uraki, R. et al. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2. Nature 607, 119\u2013127 (2022).","journal-title":"Nature"},{"key":"5697_CR11","doi-asserted-by":"publisher","first-page":"n3104","DOI":"10.1136\/bmj.n3104","volume":"375","author":"O Dyer","year":"2021","unstructured":"Dyer, O. Covid-19: Omicron is causing more infections but fewer hospital admissions than delta, South African data show. Br. Med. J. 375, n3104 (2021).","journal-title":"Br. Med. J."},{"key":"5697_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41577-022-00678-4","volume":"22","author":"A Sigal","year":"2022","unstructured":"Sigal, A. Milder disease with Omicron: is it the virus or the pre-existing immunity? Nat. Rev. Immunol. 22, 69\u201371 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"5697_CR13","unstructured":"WHO. Tracking SARS-CoV-2 variants https:\/\/www.who.int\/en\/activities\/tracking-SARS-CoV-2-variants\/ (2022)."},{"key":"5697_CR14","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41586-021-04387-1","volume":"602","author":"S Cele","year":"2022","unstructured":"Cele, S. et al. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization. Nature 602, 654\u2013656 (2022).","journal-title":"Nature"},{"key":"5697_CR15","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3201\/eid2802.212422","volume":"28","author":"H Gu","year":"2022","unstructured":"Gu, H. et al. Probable transmission of SARS-CoV-2 omicron variant in quarantine hotel, Hong Kong, China, November 2021. Emerg. Infect. Dis. 28, 460\u2013462 (2022).","journal-title":"Emerg. Infect. Dis."},{"key":"5697_CR16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.15585\/mmwr.mm7104e4","volume":"71","author":"AD Iuliano","year":"2022","unstructured":"Iuliano, A. D. et al. Trends in disease severity and health care utilization during the early Omicron variant period compared with previous SARS-CoV-2 high transmission periods\u2014United States, December 2020\u2013January 2022. Morb. Mortal. Wkly Rep. 71, 146\u2013152 (2022).","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"5697_CR17","unstructured":"CDC. COVID Data Tracker https:\/\/covid.cdc.gov\/covid-data-tracker\/#variant-proportions (2022)."},{"key":"5697_CR18","doi-asserted-by":"publisher","first-page":"o66","DOI":"10.1136\/bmj.o66","volume":"376","author":"L Taylor","year":"2022","unstructured":"Taylor, L. Covid-19: Omicron drives weekly record high in global infections. Br. Med. J. 376, o66 (2022).","journal-title":"Br. Med. J."},{"key":"5697_CR19","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.cell.2021.12.046","volume":"185","author":"W Dejnirattisai","year":"2022","unstructured":"Dejnirattisai, W. et al. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. Cell 185, 467\u2013484 (2022).","journal-title":"Cell"},{"key":"5697_CR20","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41586-022-04462-1","volume":"603","author":"R Suzuki","year":"2022","unstructured":"Suzuki, R. et al. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Nature 603, 700\u2013705 (2022).","journal-title":"Nature"},{"key":"5697_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28246-3","volume":"13","author":"DS Smyth","year":"2022","unstructured":"Smyth, D. S. et al. Tracking cryptic SARS-CoV-2 lineages detected in NYC wastewater. Nat. Commun. 13, 635 (2022).","journal-title":"Nat. Commun."},{"key":"5697_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.15585\/mmwr.mm7103a5","volume":"71","author":"AE Kirby","year":"2022","unstructured":"Kirby, A. E. et al. Notes from the field: early evidence of the SARS-CoV-2 B.1.1.529 (Omicron) variant in community wastewater\u2014United States, November\u2013December 2021. Morb. Mortal. Wkly Rep. 71, 103\u2013105 (2022).","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"5697_CR23","doi-asserted-by":"publisher","first-page":"10188","DOI":"10.3390\/ijms221910188","volume":"22","author":"A Herrmann","year":"2021","unstructured":"Herrmann, A. et al. Cloning of a passage-free SARS-CoV-2 genome and mutagenesis using red recombination. Int. J. Mol. Sci. 22, 10188 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"5697_CR24","doi-asserted-by":"publisher","unstructured":"Liu, G. & Gack, M. U. An optimized circular polymerase extension reaction-based method for functional analysis of SARS-CoV-2. Preprint at https:\/\/doi.org\/10.1101\/2022.11.26.518005 (2022).","DOI":"10.1101\/2022.11.26.518005"},{"key":"5697_CR25","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","volume":"603","author":"B Meng","year":"2022","unstructured":"Meng, B. et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity. Nature 603, 706\u2013714 (2022).","journal-title":"Nature"},{"key":"5697_CR26","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/s41564-022-01143-7","volume":"7","author":"BJ Willett","year":"2022","unstructured":"Willett, B. J. et al. SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nat. Microbiol. 7, 1161\u20131179 (2022).","journal-title":"Nat. Microbiol."},{"key":"5697_CR27","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.3201\/eid2609.202095","volume":"26","author":"RB Martines","year":"2020","unstructured":"Martines, R. B. et al. Pathology and pathogenesis of SARS-CoV-2 associated with fatal coronavirus disease, United States. Emerg. Infect. Dis. 26, 2005\u20132015 (2020).","journal-title":"Emerg. Infect. Dis."},{"key":"5697_CR28","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.stem.2020.09.013","volume":"27","author":"J Huang","year":"2020","unstructured":"Huang, J. et al. SARS-CoV-2 infection of pluripotent stem cell-derived human lung alveolar type 2 cells elicits a rapid epithelial-intrinsic inflammatory response. Cell Stem Cell 27, 962\u2013973 (2020).","journal-title":"Cell Stem Cell"},{"key":"5697_CR29","doi-asserted-by":"publisher","first-page":"109055","DOI":"10.1016\/j.celrep.2021.109055","volume":"35","author":"A Mulay","year":"2021","unstructured":"Mulay, A. et al. SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery. Cell Rep. 35, 109055 (2021).","journal-title":"Cell Rep."},{"key":"5697_CR30","doi-asserted-by":"publisher","first-page":"111359","DOI":"10.1016\/j.celrep.2022.111359","volume":"40","author":"S Liu","year":"2022","unstructured":"Liu, S., Selvaraj, P., Sangare, K., Luan, B. & Wang, T. T. Spike protein-independent attenuation of SARS-CoV-2 Omicron variant in laboratory mice. Cell Rep. 40, 111359 (2022).","journal-title":"Cell Rep."},{"key":"5697_CR31","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3390\/v14030535","volume":"14","author":"M Carossino","year":"2022","unstructured":"Carossino, M. et al. Fatal neurodissemination and SARS-CoV-2 tropism in K18-hACE2 mice is only partially dependent on hACE2 expression. Viruses 14, 535 (2022).","journal-title":"Viruses"},{"key":"5697_CR32","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","volume":"41","author":"Y Huang","year":"2020","unstructured":"Huang, Y., Yang, C., Xu, X. F., Xu, W. & Liu, S. W. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol. Sin. 41, 1141\u20131149 (2020).","journal-title":"Acta Pharmacol. Sin."},{"key":"5697_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"J Lan","year":"2020","unstructured":"Lan, J. et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215\u2013220 (2020).","journal-title":"Nature"},{"key":"5697_CR34","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1126\/science.abc6952","volume":"369","author":"X Chi","year":"2020","unstructured":"Chi, X. et al. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2. Science 369, 650\u2013655 (2020).","journal-title":"Science"},{"key":"5697_CR35","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1126\/science.abg5268","volume":"372","author":"WN Voss","year":"2021","unstructured":"Voss, W. N. et al. Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes. Science 372, 1108\u20131112 (2021).","journal-title":"Science"},{"key":"5697_CR36","doi-asserted-by":"publisher","first-page":"eabc8413","DOI":"10.1126\/sciimmunol.abc8413","volume":"5","author":"L Premkumar","year":"2020","unstructured":"Premkumar, L. et al. The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients. Sci. Immunol. 5, eabc8413 (2020).","journal-title":"Sci. Immunol."},{"key":"5697_CR37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","volume":"584","author":"B Ju","year":"2020","unstructured":"Ju, B. et al. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature 584, 115\u2013119 (2020).","journal-title":"Nature"},{"key":"5697_CR38","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","volume":"183","author":"L Piccoli","year":"2020","unstructured":"Piccoli, L. et al. Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology. Cell 183, 1024\u20131042 (2020).","journal-title":"Cell"},{"key":"5697_CR39","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41684-021-00755-6","volume":"50","author":"MC Chang","year":"2021","unstructured":"Chang, M. C., Hild, S. & Grieder, F. Nonhuman primate models for SARS-CoV-2 research: consider alternatives to macaques. Lab Anim. 50, 113\u2013114 (2021).","journal-title":"Lab Anim."},{"key":"5697_CR40","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/v13010132","volume":"13","author":"P Kumari","year":"2021","unstructured":"Kumari, P. et al. Neuroinvasion and encephalitis following intranasal inoculation of SARS-CoV-2 in K18-hACE2 mice. Viruses 13, 132 (2021).","journal-title":"Viruses"},{"key":"5697_CR41","doi-asserted-by":"publisher","unstructured":"Peacock, T. P. et al. The altered entry pathway and antigenic distance of the SARS-CoV-2 Omicron variant map to separate domains of spike protein. Preprint at https:\/\/doi.org\/10.1101\/2021.12.31.474653 (2022).","DOI":"10.1101\/2021.12.31.474653"},{"key":"5697_CR42","doi-asserted-by":"publisher","unstructured":"Padmanabhan, P. & Dixit, N. M. Modelling how the altered usage of cell entry pathways by the SARS-CoV-2 Omicron variant may affect the efficacy and synergy of TMPRSS2 and cathepsin B\/L inhibitors. Preprint at https:\/\/doi.org\/10.1101\/2022.01.13.476267 (2022).","DOI":"10.1101\/2022.01.13.476267"},{"key":"5697_CR43","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41586-022-04479-6","volume":"603","author":"KPY Hui","year":"2022","unstructured":"Hui, K. P. Y. et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature 603, 715\u2013720 (2022).","journal-title":"Nature"},{"key":"5697_CR44","doi-asserted-by":"publisher","first-page":"e1010171","DOI":"10.1371\/journal.ppat.1010171","volume":"18","author":"J Grau-Exposito","year":"2022","unstructured":"Grau-Exposito, J. et al. Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells. PLoS Pathog. 18, e1010171 (2022).","journal-title":"PLoS Pathog."},{"key":"5697_CR45","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/22221751.2021.2023329","volume":"11","author":"H Zhao","year":"2022","unstructured":"Zhao, H. et al. SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells. Emerg. Microbes Infect. 11, 277\u2013283 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"5697_CR46","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/s41586-022-04835-6","volume":"606","author":"S Ricciardi","year":"2022","unstructured":"Ricciardi, S. et al. The role of NSP6 in the biogenesis of the SARS-CoV-2 replication organelle. Nature 606, 761\u2013768 (2022).","journal-title":"Nature"},{"key":"5697_CR47","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/s41418-021-00916-7","volume":"29","author":"X Sun","year":"2022","unstructured":"Sun, X. et al. SARS-CoV-2 non-structural protein 6 triggers NLRP3-dependent pyroptosis by targeting ATP6AP1. Cell Death Differ. 29, 1240\u20131254 (2022).","journal-title":"Cell Death Differ."},{"key":"5697_CR48","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.4161\/auto.29309","volume":"10","author":"EM Cottam","year":"2014","unstructured":"Cottam, E. M., Whelband, M. C. & Wileman, T. Coronavirus NSP6 restricts autophagosome expansion. Autophagy 10, 1426\u20131441 (2014).","journal-title":"Autophagy"},{"key":"5697_CR49","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1016\/j.jinf.2020.03.058","volume":"81","author":"D Benvenuto","year":"2020","unstructured":"Benvenuto, D. et al. Evolutionary analysis of SARS-CoV-2: how mutation of non-structural protein 6 (NSP6) could affect viral autophagy. J. Infect. 81, e24\u2013e27 (2020).","journal-title":"J. Infect."},{"key":"5697_CR50","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1128\/JVI.76.8.3697-3708.2002","volume":"76","author":"R Gosert","year":"2002","unstructured":"Gosert, R., Kanjanahaluethai, A., Egger, D., Bienz, K. & Baker, S. C. RNA replication of mouse hepatitis virus takes place at double-membrane vesicles. J. Virol 76, 3697\u20133708 (2002).","journal-title":"J. Virol"},{"key":"5697_CR51","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.chom.2021.01.014","volume":"29","author":"Z Liu","year":"2021","unstructured":"Liu, Z. et al. Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization. Cell Host Microbe 29, 477\u2013488 (2021).","journal-title":"Cell Host Microbe"},{"key":"5697_CR52","doi-asserted-by":"publisher","first-page":"830527","DOI":"10.3389\/fimmu.2021.830527","volume":"12","author":"M Shah","year":"2021","unstructured":"Shah, M. & Woo, H. G. Omicron: a heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escapes approved CO VID-19 therapeutic antibodies. Front. Immunol. 12, 830527 (2021).","journal-title":"Front. Immunol."},{"key":"5697_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28882-9","volume":"13","author":"G Ye","year":"2022","unstructured":"Ye, G., Liu, B. & Li, F. Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain. Nat. Commun. 13, 1214 (2022).","journal-title":"Nat. Commun."},{"key":"5697_CR54","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41586-022-04399-5","volume":"602","author":"JM Carreno","year":"2022","unstructured":"Carreno, J. M. et al. Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron. Nature 602, 682\u2013688 (2022).","journal-title":"Nature"},{"key":"5697_CR55","doi-asserted-by":"publisher","first-page":"109014","DOI":"10.1016\/j.celrep.2021.109014","volume":"35","author":"S Torii","year":"2021","unstructured":"Torii, S. et al. Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction. Cell Rep. 35, 109014 (2021).","journal-title":"Cell Rep."},{"key":"5697_CR56","doi-asserted-by":"publisher","first-page":"e0086221","DOI":"10.1128\/JVI.00862-21","volume":"95","author":"DY Chen","year":"2021","unstructured":"Chen, D. Y. et al. SARS-CoV-2 disrupts proximal elements in the JAK-STAT Pathway. J. Virol. 95, e0086221 (2021).","journal-title":"J. Virol."},{"key":"5697_CR57","doi-asserted-by":"publisher","first-page":"e0261045","DOI":"10.1371\/journal.pone.0261045","volume":"17","author":"PL Tzou","year":"2022","unstructured":"Tzou, P. L., Tao, K., Pond, S. L. K. & Shafer, R. W. Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons. PLoS ONE\u00a017, e0261045 (2022).","journal-title":"PLoS ONE"},{"key":"5697_CR58","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/s41564-020-0770-5","volume":"5","author":"A Rambaut","year":"2020","unstructured":"Rambaut, A. et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat. Microbiol. 5, 1403\u20131407 (2020).","journal-title":"Nat. Microbiol."},{"key":"5697_CR59","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.21105\/joss.03773","volume":"6","author":"RC Aksamentov I","year":"2021","unstructured":"Aksamentov I, R. C., Hodcroft, E. & Neher, R. Nextclade: clade assignment, mutation calling and quality control for viral genomes. J. Open Source Softw. 6, 3773 (2021).","journal-title":"J. Open Source Softw."},{"key":"5697_CR60","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1038\/s41596-019-0220-0","volume":"14","author":"A Jacob","year":"2019","unstructured":"Jacob, A. et al. Derivation of self-renewing lung alveolar epithelial type II cells from human pluripotent stem cells. Nat. Protoc. 14, 3303\u20133332 (2019).","journal-title":"Nat. Protoc."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-05697-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-05697-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-05697-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T13:08:04Z","timestamp":1677676084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-05697-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,11]]},"references-count":60,"journal-issue":{"issue":"7950","published-print":{"date-parts":[[2023,3,2]]}},"alternative-id":["5697"],"URL":"https:\/\/doi.org\/10.1038\/s41586-023-05697-2","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,11]]},"assertion":[{"value":"16 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.N.K. is an inventor on US patent 10,960,070B2, entitled \u2018Prefusion coronavirus spike proteins and their use\u2019. M.S. is an inventor on a pending patent entitled \u2018Immunogenic compositions and use thereof\u2019 (USSN: 17\/463,429). Y.K. received unrelated funding from Abbott Laboratories to assess the durability of SARS-CoV-2 antibodies for healthcare workers. M.B. received funds from ARCA Biopharma for unrelated COVID-19 research. F.D. received funding from Moderna, Flagship Pioneering and ARCA Biopharma for unrelated research. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}